Kieffer Tara Lynn's Form 4 filing
Enanta Pharmaceuticals Inc (ENTA) · filed Dec 6, 2023
- Accession no.
- 0001062993-23-022055
- Filed
- Dec 6, 2023
- Trade date
- Dec 5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $20.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kieffer Tara LynnCIK 0001834835 | Officer (Sr. VP, New Prod. Strat. & Dev) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 | Common Stock | SSaleDisposed | −2,125 | $9.63 | −$20,463.75 | 37,260 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.